483 related articles for article (PubMed ID: 24395888)
1. Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids.
Ramesh R; Kozhaya L; McKevitt K; Djuretic IM; Carlson TJ; Quintero MA; McCauley JL; Abreu MT; Unutmaz D; Sundrud MS
J Exp Med; 2014 Jan; 211(1):89-104. PubMed ID: 24395888
[TBL] [Abstract][Full Text] [Related]
2. T cells: Spotting the troublemakers.
Bordon Y
Nat Rev Immunol; 2014 Feb; 14(2):64-5. PubMed ID: 24457476
[No Abstract] [Full Text] [Related]
3. Immunological disorders: Spotting the troublemakers.
Bordon Y
Nat Rev Drug Discov; 2014 Feb; 13(2):103. PubMed ID: 24481305
[No Abstract] [Full Text] [Related]
4. TH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitis.
Wedebye Schmidt EG; Larsen HL; Kristensen NN; Poulsen SS; Lynge Pedersen AM; Claesson MH; Pedersen AE
Inflamm Bowel Dis; 2013 Jul; 19(8):1567-76. PubMed ID: 23689808
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 and IL-23 plus IL-1β differentially regulate the Th1/Th17 immune response of human CD161(+) CD4(+) memory T cells.
Barrie A; Khare A; Henkel M; Zhang Y; Barmada MM; Duerr R; Ray A
Clin Transl Sci; 2011 Aug; 4(4):268-73. PubMed ID: 21884514
[TBL] [Abstract][Full Text] [Related]
6. HIF-1α-induced xenobiotic transporters promote Th17 responses in Crohn's disease.
Xie A; Robles RJ; Mukherjee S; Zhang H; Feldbrügge L; Csizmadia E; Wu Y; Enjyoji K; Moss AC; Otterbein LE; Quintana FJ; Robson SC; Longhi MS
J Autoimmun; 2018 Nov; 94():122-133. PubMed ID: 30098863
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease.
Dige A; Støy S; Rasmussen TK; Kelsen J; Hvas CL; Sandahl TD; Dahlerup JF; Deleuran B; Agnholt J
J Crohns Colitis; 2013 Apr; 7(3):248-55. PubMed ID: 22784949
[TBL] [Abstract][Full Text] [Related]
8. The roles of IFN-γ versus IL-17 in pathogenic effects of human Th17 cells on synovial fibroblasts.
Kato H; Endres J; Fox DA
Mod Rheumatol; 2013 Nov; 23(6):1140-50. PubMed ID: 23306426
[TBL] [Abstract][Full Text] [Related]
9. Increase of Intermediate Monocytes in Graft-versus-Host Disease: Correlation with MDR1
Reinhardt-Heller K; Hirschberg I; Lang P; Vogl T; Handgretinger R; Bethge WA; Holzer U
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2057-2064. PubMed ID: 28807771
[TBL] [Abstract][Full Text] [Related]
10. Expression of IL-17F is associated with non-pathogenic Th17 cells.
Wanke F; Tang Y; Gronke K; Klebow S; Moos S; Hauptmann J; Shanmugavadivu A; Regen T; Mufazalov IA; Gabriel LA; Reißig S; Diefenbach A; Kurschus FC; Waisman A
J Mol Med (Berl); 2018 Aug; 96(8):819-829. PubMed ID: 29959474
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress modulates the cytokine response of differentiated Th17 and Th1 cells.
Abimannan T; Peroumal D; Parida JR; Barik PK; Padhan P; Devadas S
Free Radic Biol Med; 2016 Oct; 99():352-363. PubMed ID: 27567538
[TBL] [Abstract][Full Text] [Related]
12. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
13. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.
Domingues HS; Mues M; Lassmann H; Wekerle H; Krishnamoorthy G
PLoS One; 2010 Nov; 5(11):e15531. PubMed ID: 21209700
[TBL] [Abstract][Full Text] [Related]
14. Brain-homing CD4
Koetzier SC; van Langelaar J; Blok KM; van den Bosch TPP; Wierenga-Wolf AF; Melief MJ; Pol K; Siepman TA; Verjans GMGM; Smolders J; Lubberts E; de Vries HE; van Luijn MM
Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 33037101
[TBL] [Abstract][Full Text] [Related]
15. Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad.
Troncone E; Marafini I; Pallone F; Monteleone G
Int Rev Immunol; 2013; 32(5-6):526-33. PubMed ID: 24041379
[TBL] [Abstract][Full Text] [Related]
16. An RORγt Oral Inhibitor Modulates IL-17 Responses in Peripheral Blood and Intestinal Mucosa of Crohn's Disease Patients.
Bassolas-Molina H; Raymond E; Labadia M; Wahle J; Ferrer-Picón E; Panzenbeck M; Zheng J; Harcken C; Hughes R; Turner M; Smith D; Calderón-Gómez E; Esteller M; Carrasco A; Esteve M; Dotti I; Corraliza AM; Masamunt MC; Arajol C; Guardiola J; Ricart E; Nabozny G; Salas A
Front Immunol; 2018; 9():2307. PubMed ID: 30405600
[No Abstract] [Full Text] [Related]
17. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation.
Kleinschek MA; Boniface K; Sadekova S; Grein J; Murphy EE; Turner SP; Raskin L; Desai B; Faubion WA; de Waal Malefyt R; Pierce RH; McClanahan T; Kastelein RA
J Exp Med; 2009 Mar; 206(3):525-34. PubMed ID: 19273624
[TBL] [Abstract][Full Text] [Related]
18. Pediatric Crohn disease is characterized by Th1 in the terminal ileum and Th1/Th17 immune response in the colon.
Savić Mlakar A; Hojsak I; Jergović M; Čimić S; Bendelja K
Eur J Pediatr; 2018 Apr; 177(4):611-616. PubMed ID: 29397417
[TBL] [Abstract][Full Text] [Related]
19. BCL-2 protects human and mouse Th17 cells from glucocorticoid-induced apoptosis.
Banuelos J; Shin S; Cao Y; Bochner BS; Morales-Nebreda L; Budinger GR; Zhou L; Li S; Xin J; Lingen MW; Dong C; Schleimer RP; Lu NZ
Allergy; 2016 May; 71(5):640-50. PubMed ID: 26752231
[TBL] [Abstract][Full Text] [Related]
20. Enrichment of IL-17A
Li J; Doty AL; Tang Y; Berrie D; Iqbal A; Tan SA; Clare-Salzler MJ; Wallet SM; Glover SC
Clin Exp Immunol; 2017 Oct; 190(1):143-153. PubMed ID: 28586085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
